BPC-157 20mg

What is BPC-157 (20mg)?

BPC-157 (20mg) is a synthetic pentadecapeptide composed of 15 amino acids. Derived from a protein fragment originally identified in human gastric juice, it has been synthesized for laboratory research applications. BPC-157 is commonly categorized as a regenerative and tissue-research peptide.

Identification Characteristics

• CAS Number: 137525-51-0
• Chemical Formula: C₆₂H₉₈N₁₆O₂₂
• Molecular Weight: 1419.5 g/mol
• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Manufactured to high-purity standards (commonly ≥98% by HPLC verification), BPC-157 (20mg) is used in preclinical models to investigate its role in tissue integrity, vascular responses, and cellular repair mechanisms. All investigations remain experimental.

What are the key features of BPC-157 (20mg)?

BPC-157 (20mg) is provided in a lyophilized powder form for precise reconstitution in laboratory experiments. Some of its key features include:

• High research-grade purity (≥98% by HPLC)
• Supplied as 20 mg lyophilized peptide in a sealed vial
• Sequence length: 15 amino acids
• Studied in tissue repair and angiogenesis research models
• Stable for up to 24 months under proper storage conditions
• For laboratory research use only

This material is intended exclusively for in vitro and preclinical investigations.

How is BPC-157 (20mg) synthesized?

BPC-157 (20mg) is synthesized using solid-phase peptide synthesis (SPPS), a standard laboratory technique for assembling short peptide chains. The 15-amino acid sequence is constructed stepwise, allowing precise control over structure and composition. Following synthesis, the peptide is purified using high-performance liquid chromatography (HPLC). Identity and molecular mass are typically confirmed through mass spectrometry (MS) analysis. The final product is lyophilized to enhance stability during storage and transport in research settings.

What is BPC-157 (20mg) being studied for? What are its possible benefits?

BPC-157 (20mg) has been studied in preclinical research models exploring connective tissue repair and vascular biology. Investigations have examined its involvement in:

• Angiogenesis research
• Muscle and tendon injury models
• Gastrointestinal mucosal research
• Ligament and soft tissue studies

In laboratory settings, BPC-157 is being investigated for its potential influence on cellular migration, extracellular matrix stability, and vascular growth signaling. These possible biological effects remain under investigation and are based on controlled experimental findings rather than clinical outcomes.

How does BPC-157 (20mg) work in research studies?

In experimental models, BPC-157 (20mg) is being researched for its interactions with signaling pathways involved in tissue repair and vascular function. Studies suggest it may influence growth factor activity and cellular communication processes involved in structural tissue maintenance. BPC-157 is thought to modulate processes that affect:

• Blood vessel formation
• Inflammation signaling
• Extracellular matrix regulation

These mechanisms are being explored in controlled laboratory models and are not indicative of clinical applications.

What dosing information exists for BPC-157 (20mg)?

Preclinical studies involving BPC-157 have primarily been conducted in animal and cell culture models. In murine research, the peptide has been studied at doses ranging from approximately 10 µg/kg to higher microgram or milligram per kilogram (mg/kg) ranges, depending on the experimental design. In in vitro studies, nanomolar to micromolar concentrations are typically used to assess cellular responses. Dosing protocols vary significantly depending on the research objective, tissue model, and duration of exposure. There are no established human dosing guidelines for BPC-157 (20mg), as it is intended exclusively for laboratory research use.

How should BPC-157 (20mg) be stored and handled?

BPC-157 (20mg) should be stored:

• As a lyophilized powder at ≤–20 °C for long-term preservation
• Shelf life: up to 24 months under recommended conditions
• Protect from light and moisture
• Room temperature exposure during shipping is acceptable
• After reconstitution, store at 2–8 °C for short-term use
• Avoid repeated freeze-thaw cycles
• Use aseptic laboratory technique during handling

Where can I read more research about BPC-157 (20mg)?

The following peer-reviewed publications provide background information on BPC-157 research:

1. He L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022;13:1026182. Published 2022 Dec 14. doi:10.3389/fphar.2022.1026182
2. Xu C, Sun L, Ren F, et al. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regul Toxicol Pharmacol. 2020;114:104665. doi:10.1016/j.yrtph.2020.104665
3. Sikiric P, Seiwerth S, Rucman R, et al. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem. 2012;19(1):126-132. doi:10.2174/092986712803414015

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.